急性髓系白血病主要分子病变的克隆层级
本研究采用18基因靶向测序 panel,追踪52例急性髓系白血病(AML)患者的突变变化与相对克隆贡献,分析了35对诊断-复发样本、27对原发样本与患者来源异种移植(PDX)以及34对总白细胞与分离的原始细胞群。结果显示复发和异种移植中主要白血病克隆保持保守,变异仅限于晚期获得的亚克隆突变;NPM1突变是最可能的白血病转化病变且保持保守,而伴随的FLT3和NRAS亚克隆突变高度变异;DNMT3A突变是最稳定的突变,在多数样本中形成白血病前背景。
要点
- AML进化主要表现为亚克隆修饰,而克隆背景保持不变。
- NPM1突变是最可能的白血病转化病变,在复发和PDX中保持保守。
- DNMT3A突变最稳定,在多数样本中形成白血病前背景。
核心结论
- AML的克隆层级中,NPM1突变是最可能的白血病转化病变,DNMT3A突变形成最稳定的白血病前背景,而FLT3和NRAS突变作为伴随亚克隆高度变异。
研究设计与样本
- 使用18基因靶向测序panel,追踪52例AML患者的突变变化与相对克隆贡献。
- 分析35对诊断与复发样本、27对原发样本与对应患者来源异种移植(PDX)、34对总白细胞与分离的原始细胞或原始细胞群。
主要发现
- 在复发和异种移植中均观察到主要白血病克隆保持保守,变异仅限于晚期获得的亚克隆突变。
- NPM1突变被确定为最可能的白血病转化病变,保持保守,而伴随的FLT3和NRAS亚克隆突变高度变异。
- DNMT3A突变是最稳定的突变,在多数样本中形成白血病前背景。
- IDH1/2、TET2、RUNX1、ASXL1和U2AF1突变既可作为白血病前病变也可作为亚克隆病变被检测到,提示获得顺序非特异。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Genetic mutations in acute myeloid leukaemia (AML) are assumed to occur in a sequential order; however, the predominant hierarchical roles of specific mutated genes have not been fully described. In this study, we aimed to determine the clonal involvement of the most frequent AML-associated mutations. Using a targeted sequencing panel for 18 genes, we traced changes and relative clonal contribution of mutations in 52 patients. We analysed 35 pairs of diagnosis and relapse samples, 27 pairs of primary samples and corresponding patient-derived xenografts, and 34 pairs of total leukocytes and corresponding isolated primitive cells or blast populations. In both relapse and xenografts, we observed conservation of main leukaemic clones and variability was limited to subclones with late-acquired mutations. AML evolution thus mainly involved modification of subclones while the clonal background remained unchanged. NPM1 mutations were identified as the most probable leukaemia-transformation lesion, remaining conserved in contrast to high variation of accompanying subclonal FLT3 and NRAS mutations. DNMT3A mutations represented the most stable mutations forming a preleukaemic background in most samples. Mutations in genes IDH1/2, TET2, RUNX1, ASXL1 and U2AF1 were detected both as preleukaemic and as subclonal lesions, suggesting a non-specific order of acquisition.
引用
- Herudkova Z, Culen M, Folta A, et al. Clonal hierarchy of main molecular lesions in acute myeloid leukaemia. Br J Haematol. 2019. PMID: 31822038. doi:10.1111/bjh.16341
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。